Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-25

FDA Approved: METFORMIN HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (TIME CAP LABORATORIES, INC)

View source ↗

Summary

FDA approved a supplemental application for Metformin Hydrochloride Extended Release from Time Cap Laboratories, Inc., bringing an extended-release formulation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin hydrochloride extended-release (metformin extended-release)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)